RICCHIUTI PETER

Average Profitability
22.74%
Insider Buys Quantity
3
Insider Buys Sum
$138,993.77
Insider Sells Quantity
30
Insider Sells Sum
$1.5M

Insider Activity of RICCHIUTI PETER

The largest purchase of all time was on 2006-02-27 and amounted to 2200 shares of Amedisys, Inc. for $69,256.

The largest sale of all time was on 2004-05-14 and amounted to 18700 shares of Amedisys, Inc. for $500,412.

Biography of RICCHIUTI PETER

No biography is available at this moment.

2015-05-05SaleAmedisys, Inc.
AMED
director
1,800
0.0054%
$27.66$49,791+45.02%
2015-03-13SaleAmedisys, Inc.
AMED
director
4,006
0.0123%
$27.25$109,166+42.71%
2014-04-02SaleAmedisys, Inc.
AMED
director
750
0.0023%
$15.31$11,479+34.84%
2014-03-04SaleAmedisys, Inc.
AMED
director
800
0.0025%
$16.66$13,326+22.89%
2013-12-03SaleAmedisys, Inc.
AMED
director
750
0.0024%
$15.89$11,918-0.95%
2012-05-23PurchaseAmedisys, Inc.
AMED
director
4,000
0.0129%
$9.55$38,191+16.8%
2011-11-04PurchaseAmedisys, Inc.
AMED
director
3,266
0.0111%
$9.66$31,546+26.73%
2010-06-02SaleAmedisys, Inc.
AMED
director
900
0.0018%
$28.45$25,610-35.66%
2010-05-04SaleAmedisys, Inc.
AMED
director
1,100
0.0023%
$32.75$36,028-41.9%
2010-04-05SaleAmedisys, Inc.
AMED
director
1,100
0.0022%
$32.26$35,486-43.15%
2010-03-02SaleAmedisys, Inc.
AMED
director
1,200
0.0024%
$34.01$40,806-45.26%
2010-02-02SaleAmedisys, Inc.
AMED
director
1,100
0.0022%
$32.20$35,415-43.4%
2010-01-05SaleAmedisys, Inc.
AMED
director
1,000
0.002%
$29.49$29,494-32.08%
2009-11-03SaleAmedisys, Inc.
AMED
director
800
0.0017%
$23.94$19,150+10.32%
2009-10-02SaleAmedisys, Inc.
AMED
director
800
0.0017%
$24.77$19,814+9.23%
2009-09-02SaleAmedisys, Inc.
AMED
director
800
0.0017%
$25.53$20,422+4.95%
2009-08-04SaleAmedisys, Inc.
AMED
director
800
0.0029%
$44.74$35,792+2.33%
2009-02-19SaleAmedisys, Inc.
AMED
director
1,000
0.0022%
$27.97$27,970-19.35%
2008-10-02SaleAmedisys, Inc.
AMED
director
600
0.0013%
$27.88$16,725-18.77%
2008-09-08SaleAmedisys, Inc.
AMED
director
700
0.0015%
$29.10$20,370-20.79%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.